RAPID DIAGNOSIS AND SELF TEST KIT
With the spread of the SARS-CoV-2 pandemic, VisMederi Pharma has become a direct importer of two lines of swabs for the diagnosis of the infection, both of which are recognized, validated and approved by the European Commission. Currently, it markets Laboratory Tests (molecular tests) and Rapid Diagnostics (nasopharyngeal and nasal antigen tests). VisMederi Pharma has organized and conducted a large study with over 500 subjects at the S. Andrea Hospital in Rome for the “Genedia” antigenic nasal and nasopharyngeal tests produced by Green Cross Medical Sciences, a prestigious Korean company. With a look towards the future, VisMederi Pharma intends to expand its line of Rapid Diagnostics and “Self-Testing” to other products (pregnancy, blood sugar, rapid antigen test for influenza, etc.).